Leveraging Bioconjugation Strategies to Enhance AOC CMC Processes

• Navigating the nuances of AOC process development and understanding how to leverage physiochemical properties and chemistry aspects between different AOCs
• Comparing AOCs with classical ADCs across payload complexity, impurity profiles, and essential analytical methods
• Assessing the evolving regulatory framework, impurity control, stability, immunogenicity and target product profiles
• Spotlighting real-world customer case studies that demonstrate a risk-managed approach to get to the clinic quicker

Speakers:

Petra Dieterich

Senior Vice President & Scientific Leader

Abzena